MTOR and Alzheimer disease: Most autophagy inducers that have been tested are based on inhibiting the autophagy suppressor mTOR, such as the well-known mTOR inhibitor rapamycin [21, 52, 53], which seems to be effective to decrease Aβ levels and prevent cognitive impairment in AD mice when used at early stages prior to the formation of extracellular plaques.